Track topics on Twitter Track topics that are important to you
Thermo Fisher Scientific's recently-acquired Brammer Bio is completing $100 million in capital expansion projects, as the viral vector CDMO looks to satisfy growing demand for gene therapies for clinical and commercial use.
The post Thermo Fisher’s Brammer Bio Completing $100M in Expansion Projects appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Article: Thermo Fisher’s Brammer Bio Completing $100M in Expansion ProjectsNEXT ARTICLE
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...